These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32518175)

  • 1. Genetic and functional insights into CDA-I prevalence and pathogenesis.
    Olijnik AA; Roy NBA; Scott C; Marsh JA; Brown J; Lauschke K; Ask K; Roberts N; Downes DJ; Brolih S; Johnson E; Xella B; Proven M; Hipkiss R; Ryan K; Frisk P; Mäkk J; Stattin EM; Sadasivam N; McIlwaine L; Hill QA; Renella R; Hughes JR; Gibbons RJ; Groth A; McHugh PJ; Higgs DR; Buckle VJ; Babbs C
    J Med Genet; 2021 Mar; 58(3):185-195. PubMed ID: 32518175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A complex comprising C15ORF41 and Codanin-1: the products of two genes mutated in congenital dyserythropoietic anaemia type I (CDA-I).
    Shroff M; Knebel A; Toth R; Rouse J
    Biochem J; 2020 May; 477(10):1893-1905. PubMed ID: 32239177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the interactions between Codanin-1 and C15Orf41, two proteins implicated in congenital dyserythropoietic anemia type I disease.
    Swickley G; Bloch Y; Malka L; Meiri A; Noy-Lotan S; Yanai A; Tamary H; Motro B
    BMC Mol Cell Biol; 2020 Mar; 21(1):18. PubMed ID: 32293259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recapitulation of erythropoiesis in congenital dyserythropoietic anaemia type I (CDA-I) identifies defects in differentiation and nucleolar abnormalities.
    Scott C; Downes DJ; Brown JM; Beagrie R; Olijnik AA; Gosden M; Schwessinger R; Fisher CA; Rose A; Ferguson DJP; Johnson E; Hill QA; Okoli S; Renella R; Ryan K; Brand M; Hughes J; Roy NBA; Higgs DR; Babbs C; Buckle VJ
    Haematologica; 2021 Nov; 106(11):2960-2970. PubMed ID: 33121234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Codanin-1 mutations engineered in human erythroid cells demonstrate role of CDAN1 in terminal erythroid maturation.
    Murphy ZC; Getman MR; Myers JA; Burgos Villar KN; Leshen E; Kurita R; Nakamura Y; Steiner LA
    Exp Hematol; 2020 Nov; 91():32-38.e6. PubMed ID: 33075436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathogenesis, diagnosis and management of congenital dyserythropoietic anaemia type I.
    Roy NBA; Babbs C
    Br J Haematol; 2019 May; 185(3):436-449. PubMed ID: 30836435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Codanin-1 mutations in congenital dyserythropoietic anemia type 1 affect HP1{alpha} localization in erythroblasts.
    Renella R; Roberts NA; Brown JM; De Gobbi M; Bird LE; Hassanali T; Sharpe JA; Sloane-Stanley J; Ferguson DJ; Cordell J; Buckle VJ; Higgs DR; Wood WG
    Blood; 2011 Jun; 117(25):6928-38. PubMed ID: 21364188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Codanin-1, the protein encoded by the gene mutated in congenital dyserythropoietic anemia type I (CDAN1), is cell cycle-regulated.
    Noy-Lotan S; Dgany O; Lahmi R; Marcoux N; Krasnov T; Yissachar N; Ginsberg D; Motro B; Resnitzky P; Yaniv I; Kupfer GM; Tamary H
    Haematologica; 2009 May; 94(5):629-37. PubMed ID: 19336738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The congenital dyserythropoieitic anemias: genetics and pathophysiology.
    King R; Gallagher PJ; Khoriaty R
    Curr Opin Hematol; 2022 May; 29(3):126-136. PubMed ID: 35441598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and molecular variability in congenital dyserythropoietic anaemia type I.
    Tamary H; Dgany O; Proust A; Krasnov T; Avidan N; Eidelitz-Markus T; Tchernia G; Geneviève D; Cormier-Daire V; Bader-Meunier B; Ferrero-Vacher C; Munzer M; Gruppo R; Fibach E; Konen O; Yaniv I; Delaunay J
    Br J Haematol; 2005 Aug; 130(4):628-34. PubMed ID: 16098079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Two Cases of Congenital Dyserythropoietic Anemia Type I Shed Light on the Uncharacterized C15orf41 Protein.
    Russo R; Marra R; Andolfo I; De Rosa G; Rosato BE; Manna F; Gambale A; Raia M; Unal S; Barella S; Iolascon A
    Front Physiol; 2019; 10():621. PubMed ID: 31191338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I.
    Babbs C; Roberts NA; Sanchez-Pulido L; McGowan SJ; Ahmed MR; Brown JM; Sabry MA; ; Bentley DR; McVean GA; Donnelly P; Gileadi O; Ponting CP; Higgs DR; Buckle VJ
    Haematologica; 2013 Sep; 98(9):1383-7. PubMed ID: 23716552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of CDAN1, C15ORF41 and SEC23B mutations in Chinese patients affected by congenital dyserythropoietic anemia.
    Wang Y; Ru Y; Liu G; Dong S; Li Y; Zhu X; Zhang F; Chang YZ; Nie G
    Gene; 2018 Jan; 640():73-78. PubMed ID: 29031773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and genetic features of congenital dyserythropoietic anemia (CDA).
    Moreno-Carralero MI; Horta-Herrera S; Morado-Arias M; Ricard-Andrés MP; Lemes-Castellano A; Abio-Calvete M; Cedena-Romero MT; González-Fernández FA; Llorente-González L; Periago-Peralta AM; de-la-Iglesia-Íñigo S; Méndez M; Morán-Jiménez MJ
    Eur J Haematol; 2018 Sep; 101(3):368-378. PubMed ID: 29901818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1.
    Dgany O; Avidan N; Delaunay J; Krasnov T; Shalmon L; Shalev H; Eidelitz-Markus T; Kapelushnik J; Cattan D; Pariente A; Tulliez M; Crétien A; Schischmanoff PO; Iolascon A; Fibach E; Koren A; Rössler J; Le Merrer M; Yaniv I; Zaizov R; Ben-Asher E; Olender T; Lancet D; Beckmann JS; Tamary H
    Am J Hum Genet; 2002 Dec; 71(6):1467-74. PubMed ID: 12434312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal presentation of congenital dyserythropoietic anemia type 1 with novel compound heterozygous CDAN1 mutations.
    Meznarich JA; Draper L; Christensen RD; Yaish HM; Luem ND; Pysher TJ; Jung G; Nemeth E; Ganz T; Ward DM
    Blood Cells Mol Dis; 2018 Jul; 71():63-66. PubMed ID: 29599085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital dyserythropoietic anemia in a Chinese family with a mutation of the CDAN1-gene.
    Ru YX; Zhu XF; Yan WW; Gao JT; Schwarz K; Heimpel H
    Ann Hematol; 2008 Sep; 87(9):751-4. PubMed ID: 18575862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR).
    Niss O; Lorsbach RB; Berger M; Chonat S; McLemore M; Buchbinder D; McCavit T; Shaffer LG; Simpson J; Schwartz JH; Meznarich J; Emberesh M; Seu KG; Zhang W; Kalfa TA;
    Blood Cells Mol Dis; 2021 Mar; 87():102534. PubMed ID: 33401150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unveiling the genetic landscape of suspected congenital dyserythropoietic anemia type I: A retrospective cohort study of 36 patients.
    Marra R; Nostroso A; Rosato BE; Esposito FM; D'Onofrio V; Iscaro A; Gambale A; Bruschi B; Coccia P; Poloni A; Unal S; Romano A; Iolascon A; Andolfo I; Russo R
    Am J Hematol; 2024 Aug; 99(8):1511-1522. PubMed ID: 38666530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital dyserythropoietic anemia in China: a case report from two families and a review.
    Ru Y; Liu G; Bai J; Dong S; Nie N; Zhang H; Zhao S; Zheng Y; Zhu X; Nie G; Zhang F; Eyden B
    Ann Hematol; 2014 May; 93(5):773-7. PubMed ID: 24196372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.